What are the brand names of drugs used to treat Multiple Sclerosis (MS)?

From the Guidelines

Multiple Sclerosis Treatment Options

The primary disease-modifying therapies for Multiple Sclerosis (MS) include interferon beta-1a (Avonex, Rebif), interferon beta-1b (Betaseron, Extavia), glatiramer acetate (Copaxone), and fingolimod (Gilenya), as evidenced by various clinical trials 1.

• Other brand name medications used to treat MS include:
  • dimethyl fumarate (Tecfidera), which is administered orally at a dose of 240mg twice daily 1
  • teriflunomide (Aubagio), with specific dosing regimens 1
  • natalizumab (Tysabri), administered intravenously at a dose of 300mg every 4 weeks 1
• Additionally, medications like alemtuzumab (Lemtrada) and ocrelizumab (Ocrevus) are used for relapsing-remitting MS, with dosing regimens typically consisting of 12mg/day for 5 days initially, followed by 12mg/day for 3 days at 12 months 1. These therapies have been shown to have varying effects on brain atrophy and disability outcomes in clinical trials, with some demonstrating a positive effect on reducing accrual of atrophy 1.

From the FDA Drug Label

What is AVONEX AVONEX is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults.

Dimethyl fumarate delayed-release capsules are a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults

What is TYSABRI TYSABRI is a prescription medicine used to treat adults with: relapsing forms of Multiple Sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.

The brand names of drugs used to treat Multiple Sclerosis (MS) are:

• AVONEX (interferon beta-1a)
• TYSABRI (natalizumab)
• Dimethyl fumarate (no brand name mentioned in the provided text, but it is known to be marketed under the brand name Tecfidera) 2, 3, 4

From the Research

Disease-Modifying Therapies for Multiple Sclerosis

The following are some of the brand names of drugs used to treat Multiple Sclerosis (MS):

• Avonex (interferon beta-1a) 5, 6, 7, 8
• Rebif (interferon beta-1a) 5, 6, 7, 8
• Betaseron (interferon beta-1b) 5, 6, 7, 8
• Extavia (interferon beta-1b) 9, 8
• Copaxone (glatiramer acetate) 5, 6, 7, 8
• Tysabri (natalizumab) 5, 6, 9, 7, 8
• Gilenya (fingolimod) 5, 6, 9, 8
• Aubagio (teriflunomide) 6, 9, 8
• Tecfidera (dimethyl fumarate) 6, 9, 8
• Lemtrada (alemtuzumab) 5, 6, 9, 8
• Ocrevus (ocrelizumab) 5, 6, 8

Emerging Therapies

Some emerging therapies for MS include:

• Laquinimod 6
• Daclizumab 6, 8
• Rituximab 8

Treatment Strategies

Treatment strategies for MS include sequential monotherapy, escalation therapy, and induction and maintenance therapy 8.